GgoogleBR first seen 16 h ago, last 14 h ago, peak #1
Retatrutide weight-loss trial shows up to 25% body weight reduction
Original: retatrutide
Retatrutide, an experimental obesity drug from Eli Lilly, is drawing major attention after trial results showed participants losing up to 25% of their body weight, reportedly making it the most powerful obesity drug tested so far. The findings are fueling discussion about the next generation of weight-loss treatments beyond semaglutide and tirzepatide, with strong interest in the US, UK and Brazil.
Why now: New trial results showing record weight loss with retatrutide have just been widely reported.
Rank over time, top of the chart is #1. 8 snapshots from 16 h ago to 14 h ago.
Evidence
- People with Type 2 diabetes lost up to 60 pounds on Lilly’s latest weight loss drug · NBC News
- Lilly's experimental drug cuts weight by 21% in diabetes trial · Reuters
- Most powerful obesity drug yet: People lost up to 25% of weight in trial · Ars Technica
Elsewhere
API: https://socialmediatrends-api.osmike.com/v1/trends/419585